Condition or Therapy: Juvenile idiopathic arthritis
Category: Rheumatology

What is the goal of this study?

Our researchers are participating in a nationwide network to learn more about juvenile idiopathic arthritis (JIA). The CARRA Registry is part of a network that provides disease and treatment information about children with rheumatic diseases. This information is used by researchers to learn more about these diseases so they can help children in the future.

Who can join the study?

This study might be a good fit if your child:

  • Was diagnosed with onset of juvenile idiopathic arthritis (JIA) before they were 16 years old.
  • Has been diagnosed with JIA within the last 6 months.
  • Has been prescribed methotrexate or a biologic medication for treatment.

What happens in the study?

If your child chooses to take part in the CARRA registry, we would review your child’s medical chart to collect information about their specific condition, including medications, results of physical exams, and long-term health outcomes. You would be given a brief questionnaire to fill out.

Who can I contact for information or to enroll?

Email the research coordinator.

Study Location(s): Seattle Children’s Hospital main campus
Principal Investigator: Dr. Sarah Ringold